A 74-year old woman was presented with dyspnoea (New York Heart Association Class III) developing over 1-week. She had inferior vena cava (IVC) inserted 6 weeks prior for proximal iliofemoral deep vein thrombosis. On chest x-ray/echocardiography this had embolized to the right ventricle (Fig. 1). The patient had severe tricuspid regurgitation as septal leaflet chordae were torn. She underwent r...

Deep vein thrombosis (DVT) is a major health problem in pregnancy and postpartum period. Catheter-directed thrombolysis (CDT) is safe and effective in the management of symptomatic DVT. Value of CDT in postpartum DVT is not fully evaluated. We describe five patients presenting with acute iliofemoral DVT in their early postpartum period who were treated with mechanical thromboaspiration and CDT....

Deep vein thrombosis (DVT) is a common disease and is associated with pulmonary embolism (PE). Proximal iliofemoral DVT may lead to severe PE and chronic venous insufficiency. The standard therapy for DVT is anticoagulant therapy using heparin and a vitamin K antagonist, but a recent clinical study showed that rivaroxaban, an oral Xa inhibitor, was comparable to standard therapy and had less bl...

conclusion pharmacomechanical thrombectomy provides very satisfactory results in a single procedure, as a new method in the treatment of acute and subacute deep vein thrombosis. background in this study, we shared the implementation success and clinical results for 38 patients treated with the cleaner™ pharmacomechanical thrombectomy device. objectives the impact and results of pharmacomechanic...

Thromboembolic phenomena are common in the elderly population and their consequences can be life threatening. Although anticoagulants are the mainstay of therapy, there are conditions in which their use is contraindicated. Alternative therapeutic options involve the use of more invasive techniques to prevent major thromboembolic incidents. We describe a case in which a modified Greenfield titan...

T he treatment of iliofemoral thrombophlebitis has changed little since the initiation of heparin use in the 1930s. Whereas current management strategies focus on the outpatient use of lowmolecular-weight heparin, treatment relies on the prevention of clot propagation rather than any effort to resolve the clot burden present. As a result, preservation of valve function is unusual, with most pat...